Evidence map›Paper›PMID 26136146›Full record

ArticlePloS one2015

Reproducibility of Variant Calls in Replicate Next Generation Sequencing Experiments.

Yuan Qi, Xiuping Liu, Chang-Gong Liu, Bailing Wang, Kenneth R Hess, W Fraser Symmans, Weiwei Shi, Lajos Pusztai

Abstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Yuan QiDepartments of Bioinformatics and Computational Biology, University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America.
Xiuping LiuDepartment of Experimental Therapeutics, University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America.
Chang-Gong LiuDepartment of Experimental Therapeutics, University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America.
Bailing WangDepartment of Breast Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America.
Kenneth R HessDepartment of Biostatistics, University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America.
W Fraser SymmansDepartment of Pathology, University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America.
Weiwei ShiYale Cancer Center, Yale School of Medicine, New Haven, Connecticut, United States of America.
Lajos PusztaiYale Cancer Center, Yale School of Medicine, New Haven, Connecticut, United States of America.

Funding

Tumor Evolution and Metastasis ProgramP30CA016672 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Scott Kopetz · 1985 to 2026
$290.8M
UTMDACC SPORE in Breast CancerP50CA116199 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI BERRY, DONALD A · 2005 to 2009
$11.9M
NCI NIH HHS 2P30 CA016672NCI NIH HHS P30 CA016672NCI NIH HHS P50 CA116199
6 · The paper itself

Abstract

Nucleotide alterations detected by next generation sequencing are not always true biological changes but could represent sequencing errors. Even highly accurate methods can yield substantial error rates when applied to millions of nucleotides. In this study, we examined the reproducibility of nucleotide variant calls in replicate sequencing experiments of the same genomic DNA. We performed targeted sequencing of all known human protein kinase genes (kinome) (~3.2 Mb) using the SOLiD v4 platform. Seventeen breast cancer samples were sequenced in duplicate (n=14) or triplicate (n=3) to assess concordance of all calls and single nucleotide variant (SNV) calls. The concordance rates over the entire sequenced region were >99.99%, while the concordance rates for SNVs were 54.3-75.5%. There was substantial variation in basic sequencing metrics from experiment to experiment. The type of nucleotide substitution and genomic location of the variant had little impact on concordance but concordance increased with coverage level, variant allele count (VAC), variant allele frequency (VAF), variant allele quality and p-value of SNV-call. The most important determinants of concordance were VAC and VAF. Even using the highest stringency of QC metrics the reproducibility of SNV calls was around 80% suggesting that erroneous variant calling can be as high as 20-40% in a single experiment. The sequence data have been deposited into the European Genome-phenome Archive (EGA) with accession number EGAS00001000826.

Indexed as

ArtifactsPolymorphism, Single NucleotideAllelesBreast NeoplasmsDNAFemaleGene FrequencyGenome, HumanHigh-Throughput Nucleotide SequencingHumansProtein KinasesReproducibility of ResultsSequence Analysis, DNADNAProtein Kinases

Identifiers

PMID26136146
PMCPMC4489803

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.